SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported)September 28, 2001
NeoPharm, Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
| 33-90516 | 51-0327886 | |
| (Commission File Number) | (IRS Employer Identification No.) |
150 Field Drive, Suite 195, Lake Forest, IL 60045
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code (847) 295-8678
________________________________________________
(Former name or former address, if changed since last report)
Item 5. Other Events and Regulation FD Disclosure
On September 28, 2001, the Issuer's Board of Directors adopted a Common Stock Repurchase Program (the "Repurchase Program"). Under the terms of the Repurchase Program, the Issuer is authorized to purchase up to 1 million shares over the next twelve months. Any purchases under the Repurchase Program may be made, from time to time, in the open market, through block trades or otherwise and, depending on market conditions and other factors, may be commenced or suspended at any time or from time to time without prior notice. Repurchased shares may be used for the Issuer's employee benefit plans, subsequent acquisitions or other general corporate purposes.
Regulation FD Disclosure
On September 28, 2001, the Issuer issued a press release relating to the authorization by the Issuer's Board of Directors of a Stock Repurchase Program. A copy of the press release is attached as Exhibit 99.1.
Item 7. Financial Statements, Pro Forma Financials and Exhibits
| Exhibit Number | Description | |
|---|---|---|
| 99.1 | Press Release dated September 28, 2001. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NEOPHARM INC. | ||||
Date: September 28, 2001 | By: | /s/ LAWRENCE A. KENYON Lawrence A. Kenyon, Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer) | ||
